Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A live-attenuated Listeria vaccine (ANZ-100) and a live-attenuated Listeria vaccine expressing mesothelin (CRS-207) for advanced cancers: phase I studies of safety and immune induction.
Le DT, Brockstedt DG, Nir-Paz R, Hampl J, Mathur S, Nemunaitis J, Sterman DH, Hassan R, Lutz E, Moyer B, Giedlin M, Louis JL, Sugar EA, Pons A, Cox AL, Levine J, Murphy AL, Illei P, Dubensky TW Jr, Eiden JE, Jaffee EM, Laheru DA. Le DT, et al. Among authors: mathur s. Clin Cancer Res. 2012 Feb 1;18(3):858-68. doi: 10.1158/1078-0432.CCR-11-2121. Epub 2011 Dec 6. Clin Cancer Res. 2012. PMID: 22147941 Free PMC article. Clinical Trial.
Impact of preexisting vector-specific immunity on vaccine potency: characterization of listeria monocytogenes-specific humoral and cellular immunity in humans and modeling studies using recombinant vaccines in mice.
Leong ML, Hampl J, Liu W, Mathur S, Bahjat KS, Luckett W, Dubensky TW Jr, Brockstedt DG. Leong ML, et al. Among authors: mathur s. Infect Immun. 2009 Sep;77(9):3958-68. doi: 10.1128/IAI.01274-08. Epub 2009 Jun 15. Infect Immun. 2009. PMID: 19528221 Free PMC article.
Biomarkers.
Esquivel RN, Mathur S, Parker C, Burgess B, Ganji G, Boss M, Lin J, Lenton S, Park L, Bailey C, Lai RYK. Esquivel RN, et al. Among authors: mathur s. Alzheimers Dement. 2025 Dec;21 Suppl 2:e103351. doi: 10.1002/alz70856_103351. Alzheimers Dement. 2025. PMID: 41449657 Clinical Trial.
A Phase II, Randomized, open-label study to evaluate low-dose Pembrolizumab plus Chemotherapy vs Chemotherapy as Neoadjuvant Therapy for localized Triple Negative Breast Cancer (TNBC). [PLANeT Trial - Pembrolizumab Low Dose in Addition to NACT in TNBC].
Arora A, Bhaskarane H, Tansir G, Bakhshi S, Gogia A, Kumar A, Jain R, Kalra K, Vishvam D, Mathur S, Rathore R, Shamim SA, Dhamija E, Rangarajan K, Tanwar P, Prasad CP, Kumar S, Gupta I, Mani K, Upadhyay AD, Diwakar MK, Vasudeva P, Verma N, Agstam S, Seenu V, Prashad R, Bansal VK, Dhar A, Krishna A, Ranjan P, Suhani S, Prakash O, Kataria K, Kumar B, Mishra A, Sharma J, Bansal B, Saikia J, Bhasker S, Haresh KP, Gupta S, Saini SK, Mallick S, Batra A. Arora A, et al. Among authors: mathur s. Ann Oncol. 2025 Dec 22:S0923-7534(25)06335-5. doi: 10.1016/j.annonc.2025.12.015. Online ahead of print. Ann Oncol. 2025. PMID: 41443410
Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study.
Halder S, Meena J, Singhal S, Kumari R, Khurana S, Mathur S, Singh A, Das SK, Malhotra N. Halder S, et al. Among authors: mathur s. Eur J Obstet Gynecol Reprod Biol. 2025 Dec 19;318:114901. doi: 10.1016/j.ejogrb.2025.114901. Online ahead of print. Eur J Obstet Gynecol Reprod Biol. 2025. PMID: 41443089
2,257 results